Tilray Medical has launched Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany.
The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content derived from novel genetic lineages. The latest product introduced under the Tilray Craft brand is Cannabisblüten THC 25 TAM.
Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, stated, "Our commitment to innovation in medical cannabis, alongside our unwavering dedication to patient care, guides our every endeavor. The launch of Tilray Craft and our new genetics, highlights our efforts to provide patients and healthcare professionals with high-quality, effective, and safe medical cannabis products. We continually assess our portfolio in collaboration with healthcare providers to address the evolving needs of our patients globally."
For more information:
Tilray
www.tilray.com